Neoadjuvant tyrosine kinase inhibitors in rectal gastrointestinal stromal tumours: a provision for enhanced oncological and functional outcomes
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1437-7772
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Neoadjuvant tyrosine kinase inhibitors in rectal gastrointestinal stromal tumours: a provision for enhanced oncological and functional outcomes ; day:2 ; month:2 ; year:2021 ; pages:1-9
International journal of clinical oncology ; (2.2.2021), 1-9
- Creator
-
Yong, Zachary Zihui
Wong, Jolene Si Min
Teo, Melissa Ching Ching
Chia, Claramae Shulyn
Ong, Chin-Ann Johnny
Farid, Mohamad
Tan, Grace Hwei Ching
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10147-021-01867-2
- URN
-
urn:nbn:de:101:1-2021032618592803569768
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yong, Zachary Zihui
- Wong, Jolene Si Min
- Teo, Melissa Ching Ching
- Chia, Claramae Shulyn
- Ong, Chin-Ann Johnny
- Farid, Mohamad
- Tan, Grace Hwei Ching
- SpringerLink (Online service)
Other Objects (12)
Analysis of long-term oncological results of clinical versus pathological responses after neoadjuvant treatment in locally advanced rectal cancer
The modified Glasgow prognostic score is a reliable predictor of oncological outcomes in patients with rectal cancer undergoing neoadjuvant chemoradiotherapy
Oncological outcome after local treatment for early stage rectal cancer
Oncological monitoring after transanal total mesorectal excision for rectal neoplasia
Oncological outcomes and quality of life after rectal cancer surgery
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Neoadjuvant therapy in pancreatic cancer: what is the true oncological benefit?
Long-term oncological outcomes after local excision of T1 rectal cancer
Nomogram for individually predicting overall survival in rectal neuroendocrine tumours
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Total neoadjuvant therapy for each locally advanced rectal cancer?
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Analysis of long-term oncological results of clinical versus pathological responses after neoadjuvant treatment in locally advanced rectal cancer
The modified Glasgow prognostic score is a reliable predictor of oncological outcomes in patients with rectal cancer undergoing neoadjuvant chemoradiotherapy
Oncological outcome after local treatment for early stage rectal cancer
Oncological monitoring after transanal total mesorectal excision for rectal neoplasia
Oncological outcomes and quality of life after rectal cancer surgery
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Neoadjuvant therapy in pancreatic cancer: what is the true oncological benefit?
Long-term oncological outcomes after local excision of T1 rectal cancer
Nomogram for individually predicting overall survival in rectal neuroendocrine tumours
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Total neoadjuvant therapy for each locally advanced rectal cancer?
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Analysis of long-term oncological results of clinical versus pathological responses after neoadjuvant treatment in locally advanced rectal cancer
The modified Glasgow prognostic score is a reliable predictor of oncological outcomes in patients with rectal cancer undergoing neoadjuvant chemoradiotherapy
Oncological outcome after local treatment for early stage rectal cancer
Oncological monitoring after transanal total mesorectal excision for rectal neoplasia
Oncological outcomes and quality of life after rectal cancer surgery
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Neoadjuvant therapy in pancreatic cancer: what is the true oncological benefit?
Long-term oncological outcomes after local excision of T1 rectal cancer
Nomogram for individually predicting overall survival in rectal neuroendocrine tumours
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Total neoadjuvant therapy for each locally advanced rectal cancer?